The Effect of Transforming Growth Factor β on Human Neuroendocrine Tumor BON Cell Proliferation and Differentiation Is Mediated through Somatostatin Signaling

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecular Cancer Research

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-07-2073PMID 18567806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor–β1‐mediated regulatory abnormalities including up‐regulation of C‐Myc and MTA1

  2007cited by this paper
• The logic of TGFbeta signaling.

  2006cited by this paper
• The logic of TGFβ signaling

  2006cited by this paper
• Dual role of transforming growth factor beta in mammary tumorigenesis and metastatic progression.

  2005cited by this paper
• Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.

  2005cited by this paper
• Smad transcription factors.

  2005cited by this paper
• Menin and TGF-beta superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast.

  2005cited by this paper
• Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis

  2005cited by this paper
• A twist for survival and cancer progression

  2005influential reference
• Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter

  2005influential reference
• The Phosphotyrosine Phosphatase η Mediates Somatostatin Inhibition of Glioma Proliferation via the Dephosphorylation of ERK1/2

  2004cited by this paper
• Somatostatin receptors and regulation of cell proliferation.

  2004cited by this paper
• Cadherin Switch in Tumor Progression

  2004cited by this paper
• Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis.

  2004cited by this paper
• Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation.

  2004influential reference
• p21 (WAF1/CIP1) Mediates the Growth Response to TGF-b in Human Epithelial Cells

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Molecular Signaling of Somatostatin Receptors

  2004cited by this paper
• The two faces of transforming growth factor beta in carcinogenesis.

  2003cited by this paper
• Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer

  2003cited by this paper
• Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

  2003cited by this paper
• Tyr‐c[D‐Orn‐Tyr(Bzl)‐Pro‐Gly]: a novel antiproliferative acting somatostatin receptor agonist with μ‐opioid receptor‐sensitizing properties

  2003cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

  2003cited by this paper
• The two faces of transforming growth factor β in carcinogenesis

  2003cited by this paper
• Autocrine growth inhibition by transforming growth factor β-1 (TGFβ-1) in human neuroendocrine tumour cells

  2003influential reference
• MEN1 tumor‐suppressor protein localizes to telomeres during meiosis

  2002cited by this paper
• Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models.

  2002cited by this paper
• Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis

  2002cited by this paper
• Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment

  2002cited by this paper
• Erratum to: Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

  2001cited by this paper
• TGF-β signaling in cancer – a double-edged sword

  2001cited by this paper
• Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

  2001cited by this paper
• TGF-beta signaling in cancer--a double-edged sword.

  2001cited by this paper
• Transcriptional Activation of Mouse sst2 Somatostatin Receptor Promoter by Transforming Growth Factor-β

  2001cited by this paper
• Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.

  2001cited by this paper
• Loss of Smad4 Function in Pancreatic Tumors

  2001cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Disruption of TGFbeta signaling pathways in human pancreatic cancer cells.

  2000cited by this paper
• Signal transduction of somatostatin receptors negatively controlling cell proliferation.

  2000cited by this paper
• Disruption of TGFβ signaling pathways in human pancreatic cancer cells

  2000cited by this paper
• Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238.

  2000cited by this paper
• Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4.

  2000cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000influential reference
• Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

  2000cited by this paper
• Peptides as regulators of the immune system: emphasis on somatostatin.

  2000cited by this paper
• sst2 Somatostatin Receptor Mediates Cell Cycle Arrest and Induction of p27 Kip1

  1999influential reference
• Activation of Somatostatin Receptor II Expression by Transcription Factors MIBP1 and SEF-2 in the Murine Brain

  1999cited by this paper
• Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas.

  1999cited by this paper
• C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest.

  1999cited by this paper
• Somatostatin and its receptor family.

  1999cited by this paper
• Transforming growth factor-beta, but not ciliary neurotrophic factor, inhibits DNA synthesis of adrenal medullary cells in vitro.

  1999cited by this paper
• Smads: transcriptional activators of TGF-beta responses.

  1998cited by this paper
• Transcriptional Activators of TGF-β Responses: Smads

  1998cited by this paper
• Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells

  1998cited by this paper
• Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness.

  1997influential reference
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• Coupling specificity between somatostatin receptor sst2A and G proteins: isolation of the receptor-G protein complex with a receptor antibody.

  1997cited by this paper
• S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ.

  1997influential reference
• Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.

  1996cited by this paper
• Inactivation of Raf-1 by a Protein-tyrosine Phosphatase Stimulated by GTP and Reconstituted by G Subunits (*)

  1996influential reference
• Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells.

  1996cited by this paper
• Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors.

  1996cited by this paper
• Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTP1C to membranes in MCF-7 human breast adenocarcinoma cells.

  1996influential reference
• Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin.

  1996cited by this paper
• Analysis of multiple molecular changes in human endocrine tumours.

  1994cited by this paper
• Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.

  1991cited by this paper
• N‐terminally extended somatostatin: The primary structure of somatostatin‐28

  1980cited by this paper
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

  1973cited by this paper
• Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.

  1968cited by this paper
• Proliferation

  1966cited by this paper

• Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review

  2025influential citation
• YAP and TEAD Are Transcriptional Regulators of Neuroendocrine Differentiation and Growth in Carcinoid Cells

  2025cites this paper
• Oncogenic pathway signatures predict the risk of progression and recurrence in well‐differentiated pancreatic neuroendocrine tumors

  2024cites this paper
• Characterization of Epithelial–Mesenchymal and Neuroendocrine Differentiation States in Pancreatic and Small Cell Ovarian Tumor Cells and Their Modulation by TGF-β1 and BMP-7

  2024cites this paper
• Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line

  2022cites this paper
• Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling

  2022influential citation
• Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms

  2022cites this paper
• Genetic Drivers of Ileal Neuroendocrine Tumors

  2021cites this paper
• Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets

  2021cites this paper
• TGF‐β1/Smad2/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells

  2021cites this paper
• Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic

  2020cites this paper
• Sustained somatostatin gene expression reverses kindling-induced increases in the number of dividing Type-1 neural stem cells in the hippocampi of behaviorally responsive rats.

  2019cites this paper
• Relationship between various cytokines implicated in asthma.

  2019cites this paper
• The tumor immune microenvironment in gastroenteropancreatic neuroendocrine neoplasms.

  2019cites this paper
• The variant at TGFBRAP1 is significantly associated with type 2 diabetes mellitus and affects diabetes‐related miRNA expression

  2018cites this paper
• Arachidonic acid-induced Ca2+ entry and migration in a neuroendocrine cancer cell line

  2018cites this paper
• Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model

  2018influential citation
• Targeting Somatostatin Receptors By Functionalized Mesoporous Silica Nanoparticles - Are We Striking Home?

  2018cites this paper
• Role of the tumor microenvironment in digestive neuroendocrine tumors

  2018cites this paper
• M3 muscarinic acetylcholine receptors regulate epithelial–mesenchymal transition, perineural invasion, and migration/metastasis in cholangiocarcinoma through the AKT pathway

  2018cites this paper
• Induced differentiation of human gingival fibroblasts into VSMC-like cells.

  2017cites this paper
• Neuroendocrine tumors and fibrosis: An unsolved mystery?

  2017cites this paper
• Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells

  2015cites this paper
• The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer

  2014cites this paper
• Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.

  2013cites this paper
• Muscarinic acetylcholine receptor M3 in proliferation and perineural invasion of cholangiocarcinoma cells.

  2012cites this paper
• The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells

  2012cites this paper
• The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells

  2012cites this paper
• The Effects of Somatostatin on Immune Cells, Functions and Diseases

  2012cites this paper
• Potential applications for cell regulatory factors in liver progenitor cell therapy.

  2011cites this paper
• The biological hallmarks of ileal carcinoids

  2011cites this paper
• Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells

  2011cites this paper
• Molecular biological examination of somatotroph pituitary adenomas related to clinical data from patients with acromegaly

  2010influential citation
• The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response.

  2010cites this paper
• GPCR Somatostatin Receptor Extracellular Loop 2 Is a Key Ectodomain for Making Subtype-Selective Antibodies With Agonist-Like Activities in the Pancreatic Neuroendocrine Tumor BON Cell Line

  2010cites this paper
• Cadherin-linked molecular mechanisms governing the terminal differentiation of human trophoblastic cells in vitro

  2010cites this paper
• New medical strategies for midgut carcinoids.

  2010cites this paper
• Stability, toxicity and differential cellular uptake of protein passivated-Fe3O4 nanoparticles

  2009cites this paper
• KRJ-I and BON Cell Lines: Defining an Appropriate Enterochromaffin Cell Neuroendocrine Tumor Model

  2009cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2008cites this paper